Eli Lilly-partnered TRexBio will apply the IPO proceeds toward clinical development of molecules designed to activate regulatory T cells to mediate immune responses and inflammation. Meanwhile, ...
Diagnostics and drug development startup Arboretum LifeSciences launched with $30 million in financing. Its executives say ...
The Series A round was led by Oak HC/FT, with participation from Norwest, .406 Ventures, Constellation Ventures, Y Combinator ...
The pace of change in digital innovation has exposed the ever-widening gap between digital health and Pharma commercial teams ...
Earlier detection is valuable, but it creates a duty that does not end when an alert appears in the electronic health record.
Cybersecurity leaders discussed how AI-driven cybersecurity attacks pose a new level of risk for hospitals and health systems ...
The AMA found that OptumRx, Express Scripts, CVS Caremark and Prime Therapeutics controlled 75% of the national PBM market in ...
Mirum Pharmaceuticals’ Atebrioz is the third FDA-approved drug for fibrodysplasia ossificans progressiva (FOP), but it brings ...
Fraud, waste, and abuse (FWA) continue to challenge dental plans as overtreatment, miscoding and inappropriate billing ...
AI could play a meaningful role in advancing social care. Not by replacing people, but by helping them and organizations ...
Nobody has ever needed convincing on what to fix. What they've lacked is a way to act on it themselves, in something close to ...
Launched last week, Facktor Ventures, an early-stage venture fund is taking a new approach to healthcare investing: they’re ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results